Ayako Kanai

Hachinohe, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Tetraspanins CD63 and CD81 as potential prognostic biomarkers in breast cancer.

Tetraspanins CD63 and CD81 as potential prognostic biomarkers in breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: September 27, 2024

Zinc transporter ZnT5 is associated with epithelial mesenchymal transition via SMAD1 in breast cancer.

Zinc transporter ZnT5 is associated with epithelial mesenchymal transition via SMAD1 in breast cancer.

Journal: International journal of experimental pathology

Published: November 29, 2023

Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients.

Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients.

Journal: Breast cancer research and treatment

Published: April 11, 2023

SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast.

SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast.

Journal: Breast cancer research and treatment

Published: April 10, 2023

FE65 defines the efficacy of tamoxifen treatment via osteopontin expression in estrogen receptor-positive breast cancer.

FE65 defines the efficacy of tamoxifen treatment via osteopontin expression in estrogen receptor-positive breast cancer.

Journal: Pathology, research and practice

Published: March 10, 2022

Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations.

Correction to: Breast cancer, diabetes mellitus and glucagon‑like peptide‑1 receptor toward exploring their possible associations.

Journal: Breast cancer research and treatment

Published: October 04, 2021

Breast Cancer, Diabetes Mellitus and Glucagon-Like Peptide-1 Receptor Toward Exploring Their Possible Associations.

Breast Cancer, Diabetes Mellitus and Glucagon-Like Peptide-1 Receptor Toward Exploring Their Possible Associations.

Journal: Breast cancer research and treatment

Published: March 27, 2021

FE65 in breast cancer and its clinicopathological significance.

FE65 in breast cancer and its clinicopathological significance.

Journal: Breast cancer (Tokyo, Japan)

Published: December 20, 2020

Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.

Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.

Journal: Breast cancer research and treatment

Published: September 06, 2019

S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.

S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: September 04, 2018

The interaction between carcinoembryonic antigen-related cell adhesion molecule 6 and human epidermal growth factor receptor 2 is associated with therapeutic efficacy of trastuzumab in breast cancer.

The interaction between carcinoembryonic antigen-related cell adhesion molecule 6 and human epidermal growth factor receptor 2 is associated with therapeutic efficacy of trastuzumab in breast cancer.

Journal: The Journal of pathology

Published: March 14, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026